RT Book, Section
A1 Ghannoum, Mahmoud
A1 Salem, Iman
A1 Christensen, Luisa
A2 Kang, Sewon
A2 Amagai, Masayuki
A2 Bruckner, Anna L.
A2 Enk, Alexander H.
A2 Margolis, David J.
A2 McMichael, Amy J.
A2 Orringer, Jeffrey S.
SR Print(0)
ID 1161343881
T1 Antifungals
T2 Fitzpatrick's Dermatology, 9e
YR 2019
FD 2019
PB McGraw-Hill Education
PP New York, NY
SN 9780071837798
LK accessmedicine.mhmedical.com/content.aspx?aid=1161343881
RD 2023/09/23
AB AT-A-GLANCETopical  agents  should  be  used  for  superficial  fungal  infections  of  limited  extent.Topical  agents  have  the  advantage  of  low  cost,  nonprescription  availability,  ease  of  use,  and  high  patient  compliance.Topical  antifungals  include  imidazoles,  allylamines,  benzylamines,  polyenes,  and  ciclopirox.A  number  of  new  carrier  vehicles  have  been  investigated  to  improve  the  bioavaliabilty  of  topical  antifungals.Systemic  agents  should  be  used  to  treat  onychomycosis  and  tinea  capitis,  or  when  superficial  fungal  infection  affects  a  large  surface  area.Attention  should  be  paid  to  drug–drug  interactions  when  prescribing  systemic  antifungals.Combination  therapy  with  topical  and  systemic  drugs  presents  several  advantages.